Topiramate injection (CyDex)

N/A

Report date: 2024/03/15 16:46:38

Base Information

Drug NameTopiramate injection (CyDex)
Drug Alias NameCaptisol-enabled (CE) TPM (CyDex)Captisol®-enabled topiramate injection (CyDex)Captisol-enabled topiramate IV (CyDex)Utibron
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channels blockersKainic acid receptor antagonistsGamma-aminobutyric acid A receptor antagonists +[5] 
TargetsSodium channelsKainic acid receptorGamma-aminobutyric acid A receptor +[5] 
Therapy Area/IndicationsMigraine DisordersEpilepsy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesCydex Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCURx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsMigraine DisordersEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A